Septic Shock
Septic Shock
Septic Shock
Dr.Younis S. Ismail
Senior clinical pharmacist
Msc. Of clinical pharmacy and therapeutics
KBMS Trainee
ISPOR, IsOP, FIP, ASHAP member
⦿ Sepsisis life-threatening organ dysfunction caused
by a dysregulated host response to infection.
Other
treatments
Vasopressor Antimicrobials
s
IV crystalloid
⦿ Forpatients with sepsis induced hypoperfusion or septic
shock at least 30 mL/ kg of IV crystalloid fluid should be
⦿ Capillaryrefill time
⦿ PLR (Passive leg raise test for 60−90 seconds) > 15% of
⦿ Starting
vasopressors peripherally rather
than delaying initiation until a central line
is secured. If vasopressor therapy is needed
beyond a short period (> 6 hr).
Vasopressor
⦿ s
We recommend using norepinephrine as
the first-line agent over other vasopressors.
⦿ For
Vasopressors
adults with septic shock and inadequate
MAP levels despite norepinephrine
⦿ (0.25-0.5mcg/kg/min), we suggest adding
epinephrine.
⦿ Epinephrine dose range (0.01 to 0.05)
mcg/kg/min.
⦿ Hydrocortisone may be considered in
patients with vasopressor-resistant at a
dose of norepinephrine ≥ 0.25 mcg/kg/
min at least 4 hours after initiation to
maintain the target MAP.
Vasopressor
s
⦿ Antimicrobials
⦿ Microbiological
samples should be assessed
as soon as possible on admission to the ED
include blood and fluid or tissue from other
sites deemed proper based on clinical
evaluation (e.g., urine or cerebrospinal
fluid).
⦿ Antimicrobials
⦿ Theadministration of an empiric
antimicrobial therapy at the time of
sepsis’s identification and after the
collection of the appropriate cultures is a
crucial step in pharmacological
management.
Antimicrobials
Vancomycin
Daptomycin Linezolid
25–30 mg/kg LD
8–10 mg/kg/day 600mg
then 20 mg/kg/bid
q12hr
⦿ MRSA
1. Previous infection/colonization by MRSA in the last 12
months
2. Hemodialysis or peritoneal dialysis
3. Presence of central venous catheters or intravascular
devices
4. Administration of multiple antibiotics in the last 30 days
(in particular with cephalosporins or fluoroquinolones)
5. Immunodepression
6. Immunosuppressor treatments
7. Rheumatoid arthritis
8. Drug addiction
9. Patients coming from long-term care facilities or who
have undergone hospital stay in the last 12 months
10. Close contact with patients colonized by MRSA
⦿ Antimicrobials
⦿ ESBL
1. Previous infection/colonization with ESBL in the last 12
months
Caspofungin Anidulafungin
70 mg LD 200 mg LD
followed by followed by
50 mg/ 24hrs 100 mg/ 24hrs
⦿ Candida
1. Immunodepression
2. Presence of central venous catheters or
intravascular devices
3. Patients in total parenteral nutrition
4. Prolonged hospitalization (>10 days, particularly
in an ICU)
5. Recent surgery (particularly abdominal surgery)
6. Prolonged wide-range antibiotic administration
7. Previous necrotizing pancreatitis
8. Recent fungal infection/colonization
⦿ Hydrocortisone
• Other treatments
• Other treatments
⦿ SurvivingSepsis Campaign: International
Guidelines for Management of Sepsis and
Septic Shock 2021.